Altogether, this indicates that POLQ inhibition induced DNA damage to ultimately trigger an influx of CD8+ T cells to suppress tumor growth in BRCA2-deficient PDAC, and STING represents a critical component of this pathway. The gene discussed is CD8A; the disease is neoplasm.